Literature DB >> 6874106

IgA isotype restriction in the mucosal but not in the extramucosal immune response after oral immunizations with cholera toxin or cholera B subunit.

N Lycke, L Lindholm, J Holmgren.   

Abstract

Intestinal mucosal as well as extramucosal antibody responses were studied in mice after peroral immunizations with cholera toxin or cholera B subunit. The immunizations with cholera toxin gave rise to a marked response with antitoxin-secreting cells (PFC) in Peyer's patches (PP), mesenteric lymph nodes (MLN) and spleen showing isotype distribution of IgG greater than IgA greater than IgM and with PFC kinetics in MLN and spleen that suggested migration of cells from PP after peroral administration rather than cells stimulated in situ by adsorbed antigen. Highest numbers of PFC were obtained after 2 immunizations, and further administrations resulted in a decrease in the PFC response in MLN and spleen, while the PP responsiveness was relatively unchanged, and interestingly, protective immunity and IgA-dominated antitoxin titers in intestinal washings increased markedly by the additional boosters. Animals immunized with cholera B subunit, which lacks the adenylate cyclase-stimulating capacity of cholera toxin, showed similar PFC responses in extramucosal organs as those receiving cholera toxin but were poorly protected and had correspondingly lower IgA antitoxin titers in intestinal washings. These results suggest that the mucosal IgA antitoxin predominance is mainly due to regulatory mechanisms operating on the end-stage differentiation of the committed B cells in lamina propria and that this differentiation, as judged from the different results with cholera toxin and its B subunit, might be influenced by cyclic AMP.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6874106     DOI: 10.1159/000234853

Source DB:  PubMed          Journal:  Int Arch Allergy Appl Immunol        ISSN: 0020-5915


  7 in total

1.  Distribution, persistence, and recall of serum and salivary antibody responses to peroral immunization with protein antigen I/II of Streptococcus mutans coupled to the cholera toxin B subunit.

Authors:  M W Russell; H Y Wu
Journal:  Infect Immun       Date:  1991-11       Impact factor: 3.441

2.  Host defense against cholera toxin is strongly CD4+ T cell dependent.

Authors:  E Hörnqvist; T J Goldschmidt; R Holmdahl; N Lycke
Journal:  Infect Immun       Date:  1991-10       Impact factor: 3.441

3.  Immunoglobulin- and J chain-producing cells associated with lymphoid follicles in the human appendix, colon and ileum, including Peyer's patches.

Authors:  K Bjerke; P Brandtzaeg
Journal:  Clin Exp Immunol       Date:  1986-05       Impact factor: 4.330

4.  Cholera antibody production in vitro by peripheral blood lymphocytes following oral immunization of humans and mice.

Authors:  N Lycke; L Lindholm; J Holmgren
Journal:  Clin Exp Immunol       Date:  1985-10       Impact factor: 4.330

5.  Strong adjuvant properties of cholera toxin on gut mucosal immune responses to orally presented antigens.

Authors:  N Lycke; J Holmgren
Journal:  Immunology       Date:  1986-10       Impact factor: 7.397

6.  Expression of cholera toxin B subunit oligomers in transgenic potato plants.

Authors:  T Arakawa; D K Chong; J L Merritt; W H Langridge
Journal:  Transgenic Res       Date:  1997-11       Impact factor: 2.788

7.  Studies on the adjuvant action of beryllium. II. Systemic effects with particular reference to secretory immunity.

Authors:  J G Hall; J Spencer
Journal:  Immunology       Date:  1984-09       Impact factor: 7.397

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.